알츠하이머, 파킨슨병 치료제 및 조기진단법 개발
Location: Spain, Community of Madrid, Madrid
Employees: 51-200
Total raised: $45M
Founded date: 2016
Investors 2
| Date | Name | Website |
| 04.06.2022 | Quantum Ve... | quantumepk... |
| - | SBI Invest... | sbik.co.kr |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 28.02.2022 | Series C | $45M | - |
Mentions in press and media 12
| Date | Title | Description | Source |
| 17.07.2023 | BIORCHESTRA Wins Grand Prize in 2023 Merck Advance Biotech G... | Recognition of outstanding in-vivo outcomes from a lead RNA program in CNS Underpinned by proprietar... | en.prnasia... |
| 01.06.2023 | BIORCHESTRA Invited to Present Update on Central Nervous Sys... | Presentation:"Successfully Achieving Intravenous (IV)-formulated RNA Delivery to the Brain, Evi... | en.prnasia... |
| 25.04.2023 | BIORCHESTRA Scientific Founder, Chairman, and Chief Executiv... | The Official State visit by the President of the Republic of Korea marks the 70th anniversary of the... | en.prnasia... |
| 24.04.2023 | BIORCHESTRA Announces Significant Progress in Studies of BMD... | Encouraging non-human primate (NHP) findings support the progression of IV-formulated BMD-001 ahead ... | en.prnasia... |
| 05.04.2023 | BIORCHESTRA Expands Executive Leadership Team with the Appoi... | CAMBRIDGE, Mass. and DAEJEON, South Korea, April 5, 2023 /PRNewswire/ -- BIORCHESTRA, a biotherapeut... | en.prnasia... |
| 27.03.2023 | BIORCHESTRA Pens a Pact Worth up to $861M for Central Nervou... | Exclusive Research and Option Agreement With Global Biopharmaceutical Company to Leverage BIORCHESTR... | en.prnasia... |
| 08.03.2023 | BIORCHESTRA Participating in Two Upcoming Therapeutic RNA-Fo... | CAMBRIDGE, Mass. and DAEJEON, South Korea, March 8, 2023 /PRNewswire/ -- BIORCHESTRA, a biotherapeut... | en.prnasia... |
| 15.12.2022 | BIORCHESTRA receives Citation from the Korean Minister of Tr... | A leader in creating jobs through the advancement of RNA-based therapeutics A contributor to a high ... | en.prnasia... |
| 09.06.2022 | BIORCHESTRA, presenting lead candidate BMD-001 for Alzheimer... | BOSTON, June 9, 2022 /PRNewswire/ -- BIORCHESTRA Co., Ltd (BIORCHESTRA), is scheduled to give a comp... | en.prnasia... |
| 28.02.2022 | Biorchestra Raises $45M in Series C Funding | Biorchestra, a Daejeon, South Korea, and Cambridge, Massachusetts, USA-based RNA therapeutics compan... | finsmes.co... |
Show more